Compare ACN & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACN | GSK |
|---|---|---|
| Founded | 1989 | 1715 |
| Country | Ireland | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2B | 116.3B |
| IPO Year | 2015 | N/A |
| Metric | ACN | GSK |
|---|---|---|
| Price | $193.71 | $57.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $270.81 | N/A |
| AVG Volume (30 Days) | ★ 5.4M | 3.9M |
| Earning Date | 03-19-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.42% | 2.95% |
| EPS Growth | ★ 6.21 | N/A |
| EPS | ★ 6.47 | N/A |
| Revenue | ★ $69,672,977,000.00 | N/A |
| Revenue This Year | $7.44 | $6.70 |
| Revenue Next Year | $5.36 | $4.22 |
| P/E Ratio | ★ $29.40 | $32.75 |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $177.50 | $35.08 |
| 52 Week High | $322.86 | $61.70 |
| Indicator | ACN | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 59.04 |
| Support Level | $187.86 | $47.89 |
| Resistance Level | $205.07 | $60.37 |
| Average True Range (ATR) | 6.53 | 1.04 |
| MACD | 0.64 | 0.45 |
| Stochastic Oscillator | 66.42 | 70.76 |
Accenture is a leading IT services firm that provides consulting, system integration, and business process outsourcing to enterprises around the world. Customers of Accenture come from a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture is the world's largest professional services company by headcount with around 800,000 employees in over 120 countries.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.